Uncommon indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

BACKGROUND: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has changed treatment for selected patients with peritoneal metastases (PM) arising from appendiceal, colorectal, epithelial ovarian, primary peritoneal and gastric cancers. However, the results of CRS wit...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Pleura Peritoneum
Glavni autori: Yee, Francis Zheng Yi, Tan, Grace Hwei Ching, Chia, Claramae Shulyn, Soo, Khee Chee, Teo, Melissa Ching Ching
Format: Artigo
Jezik:Inglês
Izdano: De Gruyter 2017
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6405028/
https://ncbi.nlm.nih.gov/pubmed/30911642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/pp-2017-0017
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items